湖北省63种药品价格、药品流通成本现状调查与规范价格政策研究  被引量:2

Study on the Situation of Price and Distribution Cost about 63 Kinds of Drugs and Policies of Regulation Price in Hubei Province

在线阅读下载全文

作  者:王竞[1] 周文犁 刘刚[1] 周延安[1] 周本宏[1] 张先洲[1] 张洪[1] 邹军[1] WANG Jing;ZHOU Wenli;LIU Gang;ZHOU Yan’an;ZHOU Benhong;ZHANG Xianzhou;ZHANG Hong;ZOU Jun(Renmin Hospital of Wuhan University,Wuhan 430060,China)

机构地区:[1]武汉大学人民医院,武汉430060

出  处:《中国药房》2018年第8期1019-1026,共8页China Pharmacy

基  金:湖北省卫生和计划生育委员会科研项目(No.WJ2015GB015)

摘  要:目的:为制定药品价格调控政策、促进药品价格合理化提供参考。方法:按照世界卫生组织和国际健康行动组织药品价格标准化调查法,对湖北省3个不同经济发展水平区域常用的、销售额较大的63种药品在各级医疗卫生机构和药品零售企业的零售价格进行抽样问卷调查(辅以现场考察),计算并统计药品中位价格比(MPR),同时以药品批发和零售企业管理人员、医院药学管理人员为对象就该省药品流通成本进行了初步访谈调查(辅以文献调查),在分析和探讨的基础上提出了控制流通成本、规范药品价格的政策建议。结果:药品价格调查共发放问卷120份,回收有效问卷118份,有效回收率为98.33%;药品流通成本调查中共有来自药品批发和零售企业、医院药学部门的30名管理人员参与了访谈。63种药品在不同类型样本单位的MPR为0.05~44.55。样本一级医疗卫生机构53种药品的67个品规中有38个(56.72%)零售价中位数高于国际参考价,样本二级医疗卫生机构63种药品的79个品规中有57个(72.15%)零售价中位数高于国际参考价,样本三级医疗卫生机构63种药品的80个品规中有63个(78.75%)零售价中位数高于国际参考价,样本药品零售企业37种药品的50个品规中有42个(84.00%)零售价中位数高于国际参考价。在所有样本单位中的MPR最高值<1的有13个品规,在1~<2之间的有12个品规,在2~<5之间的有23个品规,在5~<10之间的有15个品规,≥10的有17个品规。药品MPR比较方面,样本三级医疗卫生机构高于样本二级、一级医疗卫生机构和药品零售企业(P<0.01),样本二级医疗卫生机构和药品零售企业高于样本一级医疗卫生机构(P<0.01),而样本二级医疗卫生机构与药品零售企业比较差异无统计学意义(P>0.05);经济发展好的区域样本单位高于经济发展中等、一般区域样本单位(P<0.01),经济发展中等区域样本单位高于经济发展一�OBJECTIVE:To provide reference for formulating drug price regulation policy and promoting reasonable drug price.METHODS:According to WHO and HAI drug price standard investigation,questionnaire survey(supplemented by field investigation)about sale price of 63 commonly used drugs with large consumption sum was conducted among 3 districts of different economic development levels in Hubei province.Median price ratio(MPR)was calculated statistically.Primary interview survey(supplemented by literature investigation)about drug distribution cost was conducted among managerial staff of pharmaceutical wholesale and retail enterprises,hospital pharmacy administrators.Suggestions were put forward to control distribution cost and standardizing drug price based on analysis and discussion.RESULTS:Totally 120 questionnaires were sent out,and 118 were effectively received,with effective recovery of 98.33%.Thirty managerial staff from drug wholesale and retail enterprises,hospital pharmacy department were interviewed for investigation of drug distribution cost.MPR of 63 drugs ranged 0.05-44.55 in different types of sample institutions.Among 67 specifications of 53 kinds of drugs,median retail price of 38 specifications(56.72%)was higher than international reference price in first-level sample medical institutions.Among 79 specifications of 63 kinds of drugs,median retail price of 57 specifications(72.15%)was higher than international reference price in second-level sample medical institutions.Among 80 specifications of 63 kinds of drugs,median retail price of 63 specifications(78.75%)was higher than international reference price in third-level sample medical institutions.Among 50 specifications of 37 kinds of drugs,median retail price of 42 specifications(84.00%)was higher than international reference price in sample pharmaceutical retail enterprises.In all sample institutions,maximum MPR of 13 specification were lower than 1;those of 12 specification ranged from 1 to<2;those of 23 specifications ranged from 2 to<5;15 specificatio

关 键 词:湖北省 药品价格 药品流通成本 药品中位价格比 调查 

分 类 号:R195[医药卫生—卫生统计学] R95[医药卫生—卫生事业管理]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象